GERGEN MARK J (President and CBO) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/4/2024ACC: 0000950170-24-001831
DirectorOfficer· President and CBO
Since Jul 2020
+297.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
297.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+125K
Price / share
—
Trade value
—
% of position
20.6%
1/2/2024
607.61K→732.61K
Total
Net shares
+125K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2024 | A · Award | +125K | — | — | 20.6% | 607.61K | 732.61K |
| Total | +125K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
172.60K shares
Shares
+172.60K
Strike price
3.38
Held after
172.60K
Exercisable
—
1/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock172.60K shares | 1/2/2024 | A · Award | +172.60K | 3.38 | — | 172.60K |